- Investing Ideas
- /
- Real Estate Healthcare Sector
Real Estate Healthcare Sector
Results
2300
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2300 companies
Verve Therapeutics
Market Cap: US$410.1m
A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.
VERV
US$4.45
7D
2.1%
1Y
-14.3%
Celcuity
Market Cap: US$409.7m
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$10.63
7D
1.8%
1Y
-32.7%
Healius
Market Cap: AU$635.4m
Provides specialty diagnostic services to consumer and practitioners in Australia.
HLS
AU$0.88
7D
-10.3%
1Y
-31.1%
Sage Therapeutics
Market Cap: US$408.3m
A biopharmaceutical company, develops and commercializes brain health medicines.
SAGE
US$6.46
7D
-1.1%
1Y
-41.9%
AngioDynamics
Market Cap: US$406.1m
A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.
ANGO
US$10.20
7D
7.9%
1Y
61.6%
Personalis
Market Cap: US$405.4m
Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
PSNL
US$4.63
7D
-3.1%
1Y
256.2%
Standard BioTools
Market Cap: US$402.6m
Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.
LAB
US$1.01
7D
9.6%
1Y
-59.3%
Benitec Biopharma
Market Cap: US$399.1m
A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.
BNTC
US$15.36
7D
16.5%
1Y
100.8%
CytomX Therapeutics
Market Cap: US$397.0m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$2.65
7D
18.8%
1Y
55.9%
Northwest Biotherapeutics
Market Cap: US$388.4m
A biotechnology company, focuses on developing personalized immune therapies for cancer.
NWBO
US$0.27
7D
-1.4%
1Y
-39.6%
COMPASS Pathways
Market Cap: US$387.3m
Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.
CMPS
US$4.16
7D
-4.6%
1Y
-43.6%
iTeos Therapeutics
Market Cap: US$383.9m
A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.
ITOS
US$10.02
7D
17.1%
1Y
-40.1%
Myriad Genetics
Market Cap: US$383.5m
A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.
MYGN
US$4.19
7D
7.2%
1Y
-81.6%
Fulcrum Therapeutics
Market Cap: US$381.6m
A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.
FULC
US$6.88
7D
6.8%
1Y
-12.4%
aTyr Pharma
Market Cap: US$378.7m
A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
ATYR
US$4.47
7D
19.2%
1Y
158.4%
Fortrea Holdings
Market Cap: US$378.5m
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
FTRE
US$4.30
7D
5.9%
1Y
-83.1%
Aura Biosciences
Market Cap: US$377.6m
A clinical-stage biotechnology company, develops precision therapies to treat solid tumors.
AURA
US$5.86
7D
-0.5%
1Y
-20.3%
American Oncology Network
Market Cap: US$376.0m
Through its subsidiaries, provides oncology management services in the United States.
AONC
US$8.00
7D
30.1%
1Y
139.5%
NIOX Group
Market Cap: UK£277.5m
Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.
NIOX
UK£0.67
7D
4.1%
1Y
-5.7%
Treace Medical Concepts
Market Cap: US$368.6m
A medical technology company, designs, manufactures, and markets medical devices in the United States.
TMCI
US$5.74
7D
-2.4%
1Y
-2.4%
Vigil Neuroscience
Market Cap: US$367.8m
A clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain in the United States.
VIGL
US$7.89
7D
0%
1Y
148.1%
Olema Pharmaceuticals
Market Cap: US$362.6m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.
OLMA
US$5.28
7D
4.8%
1Y
-45.5%
Organogenesis Holdings
Market Cap: US$361.5m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$2.74
7D
-5.5%
1Y
-0.4%
Imricor Medical Systems
Market Cap: AU$557.4m
A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.
IMR
AU$1.74
7D
11.9%
1Y
258.8%
Australian Clinical Labs
Market Cap: AU$553.9m
Provides pathology diagnostic services in Australia.
ACL
AU$2.85
7D
-3.4%
1Y
24.5%
Checkpoint Therapeutics
Market Cap: US$356.8m
A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.
CKPT
US$4.26
7D
1.7%
1Y
124.2%
Mereo BioPharma Group
Market Cap: US$351.4m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
MREO
US$2.15
7D
-4.0%
1Y
-37.7%
Emergent BioSolutions
Market Cap: US$350.6m
A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.
EBS
US$6.32
7D
-1.3%
1Y
10.9%
HCW Biologics
Market Cap: US$349.7m
A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.
HCWB
US$7.73
7D
-7.6%
1Y
-82.3%
Absci
Market Cap: US$349.5m
Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.
ABSI
US$2.65
7D
-0.4%
1Y
-37.1%
Rigel Pharmaceuticals
Market Cap: US$349.0m
A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.
RIGL
US$19.20
7D
1.3%
1Y
96.4%
Clinuvel Pharmaceuticals
Market Cap: AU$539.1m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.78
7D
1.2%
1Y
-32.2%
TruBridge
Market Cap: US$345.8m
Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.
TBRG
US$23.93
7D
0.8%
1Y
154.3%
Arcturus Therapeutics Holdings
Market Cap: US$345.2m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$12.53
7D
2.7%
1Y
-67.7%
Anbio Biotechnology
Market Cap: US$340.2m
Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.
NNNN
US$7.87
7D
2.2%
1Y
n/a
ClearPoint Neuro
Market Cap: US$338.3m
Operates as a medical device company primarily in the United States.
CLPT
US$11.81
7D
-0.7%
1Y
117.5%